The ad_genetic_risk_loci dataset identifies PLCG2 rs72824905 as a rare protective AD variant with a strong protective odds-ratio proxy. The notebook's Enrichr and GTEx analysis places PLCG2 in a microglial immune signaling module with actionable phospholipase biology. Hypothesis: partial, pathway-biased PLCG2 activation can increase microglial plaque and debris clearance while avoiding broad inflammatory gain-of-function toxicity.
## Mechanistic Overview
PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction starts from the claim that modulating PLCG2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction Mechanism of Action Phospholipase C Gamma 2 represents a pivotal enzymatic node in microglial signal transduction
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
PLCG2Microglial ImmunityNeuroinflammation
Convergent signals
PLCG2 recurs across 2 selected hypotheses with aligned directionality in microglial immunity, neuroinflammation.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
7/11
dimensions won
Calibrated PLCG2 activation can reproduc
4/11
dimensions won
PLCG2 Allosteric Modulation as a Precisi
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
0.65
Evidence
0.66
0.50
Novelty
0.64
0.70
Feasibility
0.58
0.40
Impact
0.72
0.65
Druggability
0.76
0.40
Safety
0.46
0.45
Competition
0.00
0.60
Data
0.78
0.55
Reproducible
0.62
0.70
KG Connect
0.50
0.66
Score Breakdown
Dimension
Calibrated PLCG2 activation ca
PLCG2 Allosteric Modulation as
Mechanistic
0.700
0.650
Evidence
0.660
0.500
Novelty
0.640
0.700
Feasibility
0.580
0.400
Impact
0.720
0.650
Druggability
0.760
0.400
Safety
0.460
0.450
Competition
0.000
0.600
Data
0.780
0.550
Reproducible
0.620
0.700
KG Connect
0.500
0.659
Evidence
Calibrated PLCG2 activation can reproduce the protective rs7
No evidence citations yet
PLCG2 Allosteric Modulation as a Precision Therapeutic for T
No evidence citations yet
Debate Excerpts
PLCG2 Allosteric Modulation as a Precision Therape